What is Fermi Inc (FRMI)?
Fermi Inc is a biotechnology company involved in the development of immunotherapies for cancer treatment. The company utilizes proprietary technologies to engineer immune cells capable of targeting and destroying cancer cells. Its research focuses on enhancing the efficacy and safety of cell-based therapies, including T-cell receptor and chimeric antigen receptor (CAR) T-cell approaches. Fermi Inc collaborates with academic institutions and industry partners to advance its pipeline. The company aims to address various cancer types by developing personalized and off-the-shelf therapeutic options. Its operations include research, clinical development, and manufacturing of cell therapy products, adhering to regulatory standards for biopharmaceuticals.
Fermi Inc Stock Price Today: Live Overview
The price today is shaped by the current market moves, as SMG Swiss Marketplace Group AG trades at $7.27. Prices have moved within the range of $6.78 to $7.36, with a daily change percentage noted at 0%.
FAQ: Fermi Inc (FRMI)
What is the current price of FRMI stock?
The last recorded price for Fermi Inc is $7.27.
Does FRMI pay dividends?
Fermi Inc does not pay dividends.
Does FRMI have a formal corporate presence or regional headquarters in the UAE?
Fermi Inc does not have an official presence in the UAE and operates through partners only.
What is FRMI best known for?
Fermi Inc is most famous for its technology development in quantum computing.
What assets are typically shown together with FRMI?
Commonly shown alongside FRMI: Lithia Motors Inc, ProShares Ultra Silver, Melco Crown
Latest shares articles



